Tag: #BronchiolitisObliterans

Introduction Lung transplantation is a life-saving procedure for patients with end-stage lung diseases, but long-term survival remains a challenge due to chronic lung allograft dysfunction (CLAD). A new study explores how Mesenchymal Stem Cell (MSC) therapy could slow or even reverse this progressive condition, particularly in bronchiolitis obliterans syndrome (BOS) patients. Visit HSPIOA for more…